RNA & Tau in Frontotemporal Dementia

Tau mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (ftdp-17) are associated with changes in alternative RNA splicing. Here is the latest research on RNA & Tau in Frontotemporal Dementia.

July 6, 2020
Open Access

C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression

Nature Communications
Yu SunJunjie U Guo
May 14, 2020
Preprint
Open Access

In vivo PET imaging of neuroinflammation in familial frontotemporal dementia

MedRxiv : the Preprint Server for Health Sciences
M. MalpettiJames B Rowe
June 3, 2020

C9orf72 suppresses systemic and neural inflammation induced by gut bacteria

Nature
Aaron BurberryKevin Eggan
July 11, 2020

PSP-FTD Complex: A Possible Variant of PSP

American Journal of Alzheimer's Disease and Other Dementias
Sunil Pradhan, Ruchika Tandon
May 13, 2020

TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression

Proceedings of the National Academy of Sciences of the United States of America
Josiah J HerzogSuzanne Paradis
May 24, 2020

Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation

Journal of Alzheimer's Disease : JAD
Ya SuXin Cheng
June 6, 2020

Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia

The Journal of Neuropsychiatry and Clinical Neurosciences
Mario F MendezGolnoush Akhlaghipour
July 10, 2020

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease

Human Brain Mapping
Sebastian G PopescuAlzheimer's Disease Neuroimaging Initiative
July 7, 2020

Peptidyl inhibition of Spt4-Spt5: Protein-protein inhibitors for targeting the transcriptional pathway related to C9orf72 expansion repeats

Journal of Cellular Biochemistry
Alexey RayevskyDmitriy Volochnyuk
July 14, 2020

Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy

Upsala Journal of Medical Sciences
Mehrnaz HaghiSeyed Morteza Najibi
May 16, 2020
Open Access

HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo

Cell Death & Disease
Simona SannaClaudia Crosio
June 18, 2020
Open Access

Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages

Frontiers in Neurology
Suzanne M ShdoKatherine P Rankin
July 1, 2020
Open Access

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia

Acta Neuropathologica Communications
Kunie AndoJean-Pierre Brion
July 2, 2020
Open Access

Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex

Annals of Clinical and Translational Neurology
Hannah E SalapaMichael C Levin
May 24, 2020
Review

Overview of sleep disturbances and their management in Parkinson plus disorders

Journal of the Neurological Sciences
Amitabh BhattacharyaPramod Kumar Pal

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/rna-tau-in-frontotemporal-dementia/4cf30e99-0a37-471e-951c-2b8a7185a8f6